420 related articles for article (PubMed ID: 8529109)
1. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.
Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD
Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109
[TBL] [Abstract][Full Text] [Related]
2. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
[TBL] [Abstract][Full Text] [Related]
3. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
Ng L; Forrest D; Haugen BR; Wood WM; Curran T
Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
[TBL] [Abstract][Full Text] [Related]
4. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
[TBL] [Abstract][Full Text] [Related]
5. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain.
Nishiyama K; Andoh S; Kitahara A; Natsume H; Mikami T; Genma R; Nakamura H
Mol Cell Endocrinol; 1998 Mar; 138(1-2):95-104. PubMed ID: 9685218
[TBL] [Abstract][Full Text] [Related]
6. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
[TBL] [Abstract][Full Text] [Related]
7. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
Zavacki AM; Harney JW; Brent GA; Larsen PR
Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
Piedrafita FJ; Ortiz MA; Pfahl M
Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
[TBL] [Abstract][Full Text] [Related]
9. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H
Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
[TBL] [Abstract][Full Text] [Related]
10. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.
Meier CA; Dickstein BM; Ashizawa K; McClaskey JH; Muchmore P; Ransom SC; Menke JB; Hao EH; Usala SJ; Bercu BB
Mol Endocrinol; 1992 Feb; 6(2):248-58. PubMed ID: 1569968
[TBL] [Abstract][Full Text] [Related]
11. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S
J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558
[TBL] [Abstract][Full Text] [Related]
12. Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors?
Hayashi Y; Weiss RE; Sarne DH; Yen PM; Sunthornthepvarakul T; Marcocci C; Chin WW; Refetoff S
J Clin Endocrinol Metab; 1995 Nov; 80(11):3246-56. PubMed ID: 7593433
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.
Zhu XG; McPhie P; Cheng SY
Endocrinology; 1997 Apr; 138(4):1456-63. PubMed ID: 9075702
[TBL] [Abstract][Full Text] [Related]
14. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.
Kitajima K; Nagaya T; Jameson JL
Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470
[TBL] [Abstract][Full Text] [Related]
15. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
Takeda T; Suzuki S; Liu RT; DeGroot LJ
J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome.
Collingwood TN; Adams M; Tone Y; Chatterjee VK
Mol Endocrinol; 1994 Sep; 8(9):1262-77. PubMed ID: 7838159
[TBL] [Abstract][Full Text] [Related]
17. The function of retinoid X receptors on negative thyroid hormone response elements.
Takeda T; Nagasawa T; Miyamoto T; Hashizume K; DeGroot LJ
Mol Cell Endocrinol; 1997 Apr; 128(1-2):85-96. PubMed ID: 9140079
[TBL] [Abstract][Full Text] [Related]
18. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
[TBL] [Abstract][Full Text] [Related]
19. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation.
Clifton-Bligh RJ; de Zegher F; Wagner RL; Collingwood TN; Francois I; Van Helvoirt M; Fletterick RJ; Chatterjee VK
Mol Endocrinol; 1998 May; 12(5):609-21. PubMed ID: 9605924
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma.
Lin KH; Zhu XG; Hsu HC; Chen SL; Shieh HY; Chen ST; McPhie P; Cheng SY
Endocrinology; 1997 Dec; 138(12):5308-15. PubMed ID: 9389515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
